What is Quicksilver Scientific?
Founded in 2013 and headquartered in Lafayette, Colorado, Quicksilver Scientific operates at the intersection of biotechnology and consumer health. The company specializes in the manufacture of sophisticated nutritional systems, with a primary focus on detoxification protocols and lipid-based delivery mechanisms. By utilizing proprietary technology to enhance the bioavailability of supplements, Quicksilver Scientific has carved out a distinct niche in the functional medicine market. Their commitment to rigorous scientific standards and high-quality manufacturing processes has established them as a trusted provider for practitioners and consumers seeking evidence-based health solutions. The firm's ability to scale its production while maintaining clinical efficacy remains a cornerstone of its business model.
How much funding has Quicksilver Scientific raised?
Quicksilver Scientific has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Quicksilver Scientific
PPP
Public-Private Partnership
What's next for Quicksilver Scientific?
With the recent influx of capital, Quicksilver Scientific is poised to enter a new phase of institutional scaling. The strategic roadmap likely involves expanding its distribution channels, investing in further research and development for its detoxification product line, and potentially exploring new international markets. As the demand for personalized health and wellness solutions continues to rise, the company is strategically aligned to capitalize on these trends. Future growth will likely be driven by the optimization of its supply chain and the continued integration of advanced delivery technologies, ensuring that the firm remains at the forefront of the nutritional supplement industry. This late-stage financing provides the necessary runway to transition from a high-growth startup to a dominant market incumbent.
See full Quicksilver Scientific company page
